BackSagimet Biosciences Overview

Sagimet Biosciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SGMT.

Quarterly EBIT

-$11.71M
41.04% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$48.74M
25.65% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)